Karen H Albritton

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Prospects for targeted therapy of synovial sarcoma
    Karen H Albritton
    Dana Farber Cancer Institute, Harvard University, Boston, Massachusetts, USA
    J Pediatr Hematol Oncol 27:219-22. 2005
  2. ncbi request reprint Sarcomas in adolescents and young adults
    Karen H Albritton
    Adolescent and Young Adult Oncology Program, Center for Sarcoma and Bone Oncology, Dana Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
    Hematol Oncol Clin North Am 19:527-46, vii. 2005
  3. ncbi request reprint Site of oncologic specialty care for older adolescents in Utah
    Karen H Albritton
    Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 25:4616-21. 2007
  4. doi request reprint Access to care
    Karen H Albritton
    Dana Farber Cancer Institute, Boston, Massachusetts, USA
    Pediatr Blood Cancer 50:1094-8. 2008
  5. doi request reprint Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib
    Katherine A Janeway
    Pediatric Oncology, Dana Farber Cancer Institute and Department of Medicine, Children s Hospital Boston, Boston, Massachusetts 02115, USA
    Pediatr Blood Cancer 52:767-71. 2009
  6. ncbi request reprint G3139 antisense oligonucleotide directed against antiapoptotic Bcl-2 enhances doxorubicin cytotoxicity in the FU-SY-1 synovial sarcoma cell line
    David E Joyner
    SARC Laboratory, Sarcoma Services, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, Utah 84112, USA
    J Orthop Res 24:474-80. 2006
  7. ncbi request reprint Malignant fibrous histiocytoma of soft tissue: an abandoned diagnosis
    R Lor Randall
    Sarcoma Services, Suite 4260, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT 84112, USA
    Am J Orthop (Belle Mead NJ) 33:602-8. 2004
  8. ncbi request reprint Diagnosis and management of synovial sarcoma
    R Lor Randall
    Sarcoma Services, Suite 4260, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT 84112, USA
    Curr Treat Options Oncol 6:449-59. 2005

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Prospects for targeted therapy of synovial sarcoma
    Karen H Albritton
    Dana Farber Cancer Institute, Harvard University, Boston, Massachusetts, USA
    J Pediatr Hematol Oncol 27:219-22. 2005
    ..The SYT-SSX fusion protein that results from the X,18 translocation is an appealing target, as are the proteins overexpressed in synovial sarcoma: bcl-2, EGFR, and HER-2/neu...
  2. ncbi request reprint Sarcomas in adolescents and young adults
    Karen H Albritton
    Adolescent and Young Adult Oncology Program, Center for Sarcoma and Bone Oncology, Dana Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
    Hematol Oncol Clin North Am 19:527-46, vii. 2005
    ....
  3. ncbi request reprint Site of oncologic specialty care for older adolescents in Utah
    Karen H Albritton
    Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 25:4616-21. 2007
    ..We used a population-based registry to determine the site of care of children, adolescents, and young adults (age 0 to 24 years) with newly diagnosed cancer...
  4. doi request reprint Access to care
    Karen H Albritton
    Dana Farber Cancer Institute, Boston, Massachusetts, USA
    Pediatr Blood Cancer 50:1094-8. 2008
    ..Such international collaboration and focus, with specific research goals are suggested in order to make variation in access to optimal care become a thing of the past...
  5. doi request reprint Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib
    Katherine A Janeway
    Pediatric Oncology, Dana Farber Cancer Institute and Department of Medicine, Children s Hospital Boston, Boston, Massachusetts 02115, USA
    Pediatr Blood Cancer 52:767-71. 2009
    ..Sunitinib prolongs survival in adult patients with imatinib-resistant gastrointestinal stromal tumor (GIST). We report the experience with sunitinib in pediatric patients with advanced GIST following failure of imatinib...
  6. ncbi request reprint G3139 antisense oligonucleotide directed against antiapoptotic Bcl-2 enhances doxorubicin cytotoxicity in the FU-SY-1 synovial sarcoma cell line
    David E Joyner
    SARC Laboratory, Sarcoma Services, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, Utah 84112, USA
    J Orthop Res 24:474-80. 2006
    ..G3139 anti-Bcl-2 intervention sensitized the FU-SY-1 SS to doxorubicin, due to increased apoptosis. G3139 intervention was ineffective in the two non-SS cell lines...
  7. ncbi request reprint Malignant fibrous histiocytoma of soft tissue: an abandoned diagnosis
    R Lor Randall
    Sarcoma Services, Suite 4260, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT 84112, USA
    Am J Orthop (Belle Mead NJ) 33:602-8. 2004
    ..In this article, we review the current understanding of the histologic subtype classification of tumors previously diagnosed as MFH and its relation to clinical outcomes...
  8. ncbi request reprint Diagnosis and management of synovial sarcoma
    R Lor Randall
    Sarcoma Services, Suite 4260, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT 84112, USA
    Curr Treat Options Oncol 6:449-59. 2005
    ..Meanwhile, carefully designed clinical trials of these agents, with translational correlates, will provide in vivo data to complement the preclinical experience...